Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis
Crossref DOI link: https://doi.org/10.1186/s13075-017-1293-1
Published Online: 2017-05-15
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grabner, Michael
Boytsov, Natalie N.
Huang, Qing
Zhang, Xiang
Yan, Tingjian
Curtis, Jeffrey R.
Funding for this research was provided by:
Eli Lilly (N/A)